Merck is one of the world's largest pharmaceutical companies. Merck reported 4% revenue ... Argus has a "buy" rating and $100 price target for GILD stock, which closed at $92.92 on Jan. 23.
A majority of U.S. senators and representatives receive campaign funding from pharmaceutical companies — an important part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback